Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study

Background: The majority of therapies have generally targeted fasting glucose control, and current mealtime insulin therapies have longer time action profiles than that of endogenously secreted insulin. The primary purpose of this study was to assess both glucose time-in-range (TIR: 70–180 mg/dL) an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Technol Ther
Autors principals: Akturk, Halis Kaan, Snell-Bergeon, Janet K., Rewers, Amanda, Klaff, Leslie J., Bode, Bruce W., Peters, Anne L., Bailey, Timothy S., Garg, Satish K.
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc., publishers 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6161328/
https://ncbi.nlm.nih.gov/pubmed/30207748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2018.0200
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars